Labyrinth One-Automated CTC Enrichment System

 

Category: *Precision Health & Smart Medical

Exhibitor: BLOODSCAN LIFE TECHNOLOGY CO., LTD.

Booth No: N/A

 

Characteristic

 

Labyrinth One - Automated Circulating Tumor Cell Enrichment System
Revolutionary Innovation for Precision Cancer Detection!!
Labyrinth One is a next-generation automated circulating tumor cell (CTC) enrichment system developed by Dr. Sunitha Nagrath, a Fellow of the University of Michigan, and launched by BloodScan Biotech. This revolutionary technology is based on a patented labyrinth microfluidic principle, utilizing the physical properties of cells and fluid dynamics, requiring no antibody labeling, and capable of rapidly and efficiently isolating high-purity viable CTC samples within just 15 minutes.
Labyrinth One can capture all CTC phenotypes, achieving a high recovery rate and viability of over 95%, and effectively removing up to 99.9999% of background blood cells. It can isolate various CTC subtypes, providing high-quality samples for unbiased downstream analysis in research and clinical applications, aiding the advancement of precision cancer detection and treatment. Its operation is simple and intuitive, with one-click processing to complete the enrichment.
By combining automation, commercial potential, and clinical collaboration scalability, Labyrinth One has the potential to promote CTC diagnostic technology into mainstream oncology clinical diagnostics. We are not just launching a product; rather, by solving the critical challenges in CTC isolation, we are transforming CTC diagnostic technology into the gold standard for precision oncology.

 

 

 

Back